Abbott's ABT growth is backed by strong improvement in global Core Laboratory Diagnostics sales, led by continued strong ...

Abbott has unveiled its next generation point of care diagnostics offering, launching it under the new brand name of Alinity. The suite of products comprises next generation immunoassay ...

with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries. Abbott will live ...

Since 2013, Abbott has continued to improve the profitability of its four segments: nutritionals, devices, diagnostics, and established pharmaceuticals. Although the company has made progress over ...

Abbott has been investing in their point-of-care diagnostics, which has seen strong revenue growth recently. Considering both the core lab and point-of-care market, I predict their revenue will ...